Suppr超能文献

阿托品-依酚氯铵合剂:剂量反应研究

Atropine-edrophonium mixture: a dose-response study.

作者信息

Naguib M, Gomaa M, Absood G H

机构信息

Department of Anesthesiology, King Faisal University, King Fahd Hospital, Al Khobar, Saudi Arabia.

出版信息

Anesth Analg. 1988 Jul;67(7):650-5.

PMID:3382038
Abstract

The dose-response and the doses required to prevent bradycardia in 50% (ED50) and 95% (ED95) of patients were determined for atropine after antagonism of pancuronium-induced neuromuscular blockade in 72 patients with edrophonium-atropine mixtures. Edrophonium 0.67 mg/kg (group A, n = 37) or 1.0 mg/kg (group B, n = 35) was randomly mixed with one of seven doses of atropine (ranging from 0.0125 to 0.0215 mg/kg in group A and from 0.02 to 0.04 mg/kg in group B); with dose-response curves for atropine being constructed for both groups 5 and 10 minutes after the injection of the mixture. These dose-response curves were found to be parallel in both groups. The calculated ED50 values of atropine were 1.6-2 times greater in group B, compared with those in group A. The estimated ED50 doses of atropine in groups A and B at 5 minutes were 0.018 and 0.029 mg/kg, respectively, and at 10 minutes, the ED50 doses were similar, being 0.016 and 0.032 mg/kg, respectively. The calculated ED95 doses of atropine in groups A and B at 5 minutes were 0.024 and 0.055 mg/kg, and at 10 minutes, the ED95 doses were also similar, being 0.027 and 0.05 mg/kg, respectively.

摘要

在72例使用依酚氯铵 - 阿托品混合物拮抗泮库溴铵诱导的神经肌肉阻滞的患者中,测定了阿托品预防心动过缓的剂量反应以及50%(ED50)和95%(ED95)患者所需的剂量。将0.67mg/kg依酚氯铵(A组,n = 37)或1.0mg/kg依酚氯铵(B组,n = 35)随机与七种剂量的阿托品之一混合(A组范围为0.0125至0.0215mg/kg,B组范围为0.02至0.04mg/kg);在注射混合物后5分钟和10分钟为两组构建阿托品的剂量反应曲线。发现两组的这些剂量反应曲线是平行的。与A组相比,B组阿托品的计算ED50值大1.6 - 2倍。A组和B组在5分钟时阿托品的估计ED50剂量分别为0.018和0.029mg/kg,在10分钟时,ED50剂量相似,分别为0.016和0.032mg/kg。A组和B组在5分钟时阿托品的计算ED95剂量分别为0.024和0.055mg/kg,在10分钟时,ED95剂量也相似,分别为0.027和0.05mg/kg。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验